M&A Makes Sense for Procognia

Procognia's acquisition of fellow Apax portfolio company Sense Proteomic could indicate a more proactive stance from VCs intent on consolidating their bets behind likely winners.

Despite the financial implosion of the German biotechnology industry, European M&A has been surprisingly rare. Management has been reluctant to give up the dream as long as some cash remains in the company and, even when they've been willing to listen to acquisition ideas, they haven't liked the valuations they're offered.

Platform companies Procognia Ltd. and Sense Proteomic Ltd. were able to get around both issues, helped by their...

In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

More from Global Vision

More from In Vivo